vimarsana.com
Home
Live Updates
Novel Mechanism Uniquely - Breaking News
Pages:
Latest Breaking News On - Novel mechanism uniquely - Page 1 : vimarsana.com
Fabre-Kramer Submits NDA Amendment for EXXUA™ for Treatment of Major Depressive Disorder
/PRNewswire/ Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) today announced that on December 23, 2022, it filed an NDA Amendment with the Food and Drug.
United states
Stephen kramer
Anitah clayton
Stephena stahl
University of california
Department of psychiatry neurobehavioral sciences
Human services
Drug administration
Neuroscience education institute
University of virginia school medicine
Us department of health
Fabre kramer pharmaceuticals inc
New class
Novel mechanism uniquely
Directly addresses important unmet
Fabre kramer pharmaceuticals
vimarsana © 2020. All Rights Reserved.